VIVA Biotech Holdings
HKEX:1873
VIVA Biotech Holdings
Tax Provision
VIVA Biotech Holdings
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
V
|
VIVA Biotech Holdings
HKEX:1873
|
Tax Provision
-¥43.8m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
WuXi AppTec Co Ltd
SSE:603259
|
Tax Provision
-¥2B
|
CAGR 3-Years
-64%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Tax Provision
-¥232.4m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Tax Provision
-¥603.2m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Tax Provision
-¥325.7m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-32%
|
|
Genscript Biotech Corp
HKEX:1548
|
Tax Provision
-$4.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
See Also
What is VIVA Biotech Holdings's Tax Provision?
Tax Provision
-43.8m
CNY
Based on the financial report for Dec 31, 2023, VIVA Biotech Holdings's Tax Provision amounts to -43.8m CNY.
What is VIVA Biotech Holdings's Tax Provision growth rate?
Tax Provision CAGR 5Y
-23%
Over the last year, the Tax Provision growth was 3%. The average annual Tax Provision growth rates for VIVA Biotech Holdings have been -25% over the past three years , -23% over the past five years .